Probi publishes annual report for 2018

Probi's Annual Report for 2018 is now available on the company website, www.probi.com under Investor Relations. Distribution of the printed annual report will start during week 16 to shareholders who subscribe to our financial reporting.

This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 8.30 CET on 10 April 2019.

FOR FURTHER INFORMATION, CONTACT:
Henrik Lundkvist, CFO, Probi, tel +46 46 286 89 41, e-post: henrik.lundkvist@probi.com

ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company. Probi’s vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2018, Probi had net sales of MSEK 604. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi had about 4,000 shareholders on December 31, 2018. Read more at www.probi.com. 

Tags: